NHS Accelerated Access Collaborative planning to launch MedTech Funding Mandate in April 2021

08

Dec 2020

In November 2020, NHS Accelerated Access Collaborative (ACC) published their plans for further introducing MedTech Funding Mandate after the COVID-19 outbreak.

According to the NHS Long Term Plan, introducing a MedTech Funding Mandate will support getting innovative medical devices, diagnostics, and digital products to patients faster. The Medtech Funding Mandate policy received strong support with clear recommendations on the criteria for inclusion technologies in 2019/20. However, the launch of the Medtech Funding Mandate was delayed due to the COVID-19 pandemic.

The MedTech Funding Mandate launch is planned for April 2021. The policy and the consultation outcome report will be published this winter to confirm the final criteria, the technologies that it will cover, and additional implementation support. ACC will highlight these technologies at least twice a year, working with the suppliers of these technologies to support their inclusion. This new policy will not affect the existing funding for technologies with a positive NICE Technology Appraisal.

To support the implementation of innovations within NHS organizations and identify barriers to their uptake, AAC will also collaborate with patients and the Academic Health Science Networks (AHSNs) to understand local and regional issues and share learning from NHS organizations already implemented the innovations.

All the recommended innovations are effective and cost-saving, so this policy will both improve patient care and save the NHS money. Hospitals and commissioning organizations are expected to comply with the policy guidance where appropriate.

See full details here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). First EU issues of both newsletters are available for download free-of-charge.

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks).

The latest related news

25

Mar 2022

On March 4, 2022, the Dutch Healthcare Institute (Zorginstituut Nederland, ZIN) announced three projects which received a subsidy under the "Subsidy scheme for promising care" in 2022 for research of a new minimally invasive endoscopy-guided surgery in patients with spontaneous cerebral hemorrhage, oral immunotherapy in children to cure a food allergy and cutting the diaphragm band in chronic abdominal complaints.

Read more

21

Mar 2022

The NHS Insights Prioritisation Programme (NIPP) is commissioned by the NHS Accelerated Access Collaborative (AAC) and the National Institute for Health Research (NIHR). It is designed to accelerate the evaluation and implementation of innovation that supports post-pandemic ways of working, builds service resilience, and delivers benefits to patients. Fourteen projects have been funded and have now commenced activity that will be ongoing until March 2023.

Read more

18

Mar 2022

On February 22, 2022, a repository of innovative acts outside the nomenclature of biology and anatomopathology (RIHN) and a Supplementary list of IVD tests were published. Minor changes were introduced in the 2022 RIHN list.

Read more

14

Mar 2022

In February 2021, the Clinical Coding and Schedule Development (CCSD) working group, which develops and maintains procedural and diagnostics nomenclature for private payers in England, published Bulletins 0182 and 0079 with changes to be implemented no later than April 10, 2022. Three new procedure codes concerned robotic surgery in orthopaedic area, spinal procedures, and ophthalmology, and five new diagnostic codes were introduced.

Read more

09

Mar 2022

On February 16, 2022, the Innovation Committee at the Federal Joint Committee (G-BA) has published the decisions which recommended the transfer to standard care for three completed projects. The projects relate to the prevention of antibiotic resistance, improvement of healthcare in socially disadvantaged areas, and misuse of control colonoscopies in Germany.

Read more